A new model can predict drug interactions and side effects even between a large number of components
Drug cocktails such as those for treating cancer, like the alcoholic versions offered at the local bar, are best when the proper ingredients are mixed in the right proportions.
Like the cocktails we normally drink, the combination of ingredients can be better than the sum of its parts – or it can leave us with unwanted side effects.
A new model developed in the group of Prof. Uri Alon of the Weizmann Institute of Science’s Molecular Cell Biology Department can simplify the process of identifying the optimal blends for drug cocktails – even when a large number of ingredients is called for.
Drug cocktails – both antibiotic and anti-cancer – are increasingly used, among other things, because simultaneously attacking pathogenic cells with several different methods can reduce the risk of drug resistance.
Doctors and pharmaceutical companies are interested in the advance of drug “Mixology” because it can help create novel applications for existing drugs, since new ones are costly to develop and slow to reach the market.
Adding drugs together does not generally result just in the sum of their effects.
One drug can alert mechanisms in a cell that pump the other drugs out of the cell, thus changing the dose at which the other drugs will be effective.
Conversely, side effects can add up, so researchers often want to identify the lowest possible dose of any given drug.
With typically four or more drugs added together in chemotherapy cocktails, the number of possible combinations and doses is astronomical: It would be impossible to test them all to arrive at the optimal mix.
Because of the combinatorial explosion problem, say research students Anat Zimmer and Itay Katzir, who led the study, drug cocktails are often concocted without any good way of predicting the end result.
Their method requires only a small number of measurements on drug pairs.
The tests are conducted on human cancer cells or bacteria grown in lab dishes.
The group tested each drug – separately and in pairs – to understand the effects at several different doses.
This enabled the researchers to determine how drug A affects the actions of B, and vice versa, and the new mathematical model the group developed was then extrapolated to predict the interactions among three, four and more drugs in combination.
Further testing showed that the model performs better than existing methods of dealing with the combinatorial explosion problem.
Thus researchers using the model would not need to test every possible combination to arrive at the optimal doses in drug cocktails.
“There is an urgent demand for methods that can predict how drug cocktails will work,” says Katzir.
“This model may take much of the expensive guesswork out of the process of developing such cocktails.”
“The model might prove especially useful for personalized medicine – for example, in cancer – because each tumor can react differently to the same drugs,” adds Zimmer.
“It provides a way to mix that perfect cocktail without having to try out all of the possible combinations.”
Learn more: How to Mix the Perfect Cocktail
Receive an email update when we add a new DRUG INTERACTION article.
The Latest on: Drug interaction
via Google News
The Latest on: Drug interaction
- Clinical Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industryon January 23, 2020 at 12:52 pm
This final guidance helps sponsors of investigational new drug applications and applicants of new drug applications evaluate drug-drug interactions (DDIs) during drug development and determine ...
- In Vitro Drug Interaction Studies — Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industryon January 23, 2020 at 12:18 pm
This final guidance is intended to help drug developers plan and evaluate studies to determine the drug-drug interaction (DDI) potential of an investigational drug product.2 The final guidance focuses ...
- Chromosome arm aneuploidies shape tumour evolution and drug responseon January 23, 2020 at 2:43 am
Additionally, machine learning identifies 31 CAAs that robustly alter response to 56 chemotherapeutic drugs across cell lines representing 17 cancer types. We also uncover 1024 potential synthetic ...
- Researchers slash pre-drug screening time from years to dayson January 22, 2020 at 7:19 am
It is an important step for both applied and theoretical scientists. Most of the promising new drugs in production are proteins that destroy certain disease-associated protein-protein interactions, ...
- Melting reveals drug targets in a living organismon January 22, 2020 at 6:51 am
In their results, published in Nature Biotechnology on 20 January, the scientists mapped protein-drug interactions in rat organs and blood. Their research opens pathways in drug discovery, fundamental ...
- New technology systematically identifies drug targets in living animalson January 21, 2020 at 5:38 am
In their results, published in Nature Biotechnology on 20 January, the scientists mapped protein–drug interactions in rat organs and blood. Their research opens pathways in drug discovery, fundamental ...
- Non-Oncology Drugs Surprisingly Capable Of Killing Cancer Cellson January 20, 2020 at 10:50 pm
Some of the nearly 50 non-cancer drugs Corsello and his colleagues identified appear to activate a protein or stabilize a protein-protein interaction and not by inhibiting a protein. According to ...
- Old Drug, New Tricks: Existing Medicines Show Promise in Fighting Canceron January 20, 2020 at 9:18 am
These included one previously approved to treat essential thrombocytosis—a blood disorder—as well as progesterone medications. The drugs all appear to work by inducing an interaction between two ...
- The vaping panic is looking eerily like the start of a new drug waron January 18, 2020 at 6:01 am
Media malpractice and political opportunism recklessly panicked the public. New prohibitions are already producing drug-war-like results.
via Bing News